Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

NCT05943535 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

698

Enrollment

INDUSTRY

Sponsor class

Conditions

Progressive Pulmonary Fibrosis
Interstitial Lung Disease

Interventions

DRUG: Placebo
DRUG: Inhaled Treprostinil
DEVICE: Treprostinil Ultrasonic Nebulizer

Sponsor

United Therapeutics